Aim: Right hemicolectomy with complete mesocolic excision (CME) requires the removal of an intact mesocolic envelope. The study aimed to determine, on the basis of macroscopic and microscopic anatomical studies, the optimal surgical dissection planes for CME to preserve fascial integrity. Unequivocal anatomical nomenclature was applied to describe the retrocolic fascial system and compared to frequently used eponyms (Toldt, Gerota, Fredet, Treitz).Method: Stepwise macroscopic dissections, cross‐section studies and histological analysis were performed on body donors to identify the components of the retrocolic fascial system. Based on these anatomical findings, the optimal surgical dissection planes for CME were validated in laparoscopic training courses on body donors and in robot‐assisted surgical procedures in patients.Results: The mesocolic tissue and lymphovascular pedicles were enveloped by the ventral and dorsal mesocolic leaf (mesocolic fascia). The mesocolic fascia was attached to the parietal peritoneal fascia (‘fascia of Toldt’) along the parieto–mesocolic interface, and further cranially to the pre‐duodenopancreatic fascia along the mesocolic–duodenopancreatic interface (‘space of Fredet’). Dorsally, the parietal peritoneal fascia was separated from the anterior renal fascia (‘fascia of Gerota’) by the parieto–renal interface. Dissection along this interface in front of the anterior renal fascia followed by incision of the parietal peritoneal fascia at the duodenal border and opening the mesocolic–duodenopancreatic interface yielded the best macroscopic appearance of specimens and was considered optimal for CME.Conclusion: The retrocolic fascial system as well as the surgical dissection planes for CME can be described by clearly defined anatomical terms rather than potentially confusing eponyms.
1 April 2022 in European Journal of Surgical Oncology
Introduction It may be possible to identify several ‘levels’ of polypectomy service within the UK, each requiring a different range of polypectomy skills: flexible sigmoidoscopy screening, non-screening colonoscopy, screening colonoscopy and the specialist endoscopy service. This requires a definition of ‘complexity levels’ of polyps, to reflect the four levels of service, each with clearly defined parameters that represent the bare minimum that an endoscopist operating at a particular level should be able to deal with competently. Methods The aim of this study was to define polyp levels to reflect the four levels of competency required to deliver a particular service, based on polyp characteristics. Consensus by nine experienced endoscopists regarding the parameters that determine the complexity of a polyp, was achieved using group meetings and the Delphi method. The same group of experts then assigned a polyp complexity level to each possible combination of factors. Results The group identified four factors to be most relevant for determining the complexity of a polypectomy: size (S), morphology (M), site (S) and access (A). In two Delphi rounds the benchmarks for each factor were evaluated (see table). After analysing the expected complexity for each polyp type as proposed by the experts, a scoring system was established, based on size (1–9 points), morphology (1–3 points), site (1–2 points) and access (1–3 points). Four polyp levels (with increasing level of complexity) were identified based on the range of expert scores obtained: Level 1 (4–5), Level 2 (6–9), Level 3 (10–12) and Level 4 (>12). Conclusion Defining polyp complexity levels may be useful for planning training, competency assessment and certification in colonoscopic polypectomy. In turn this may allow for more efficient service delivery and referral onto specialist centres where appropriate. PWE-010 Competing interests None.
Background: The quality of care of patients receiving colorectal resections has conventionally relied on individual metrics. When discussing with patients what these outcomes mean, they often find them confusing or overwhelming. Textbook oncological outcome (TOO) is a composite measure that summarises all the ‘desirable’ or ‘ideal’ postoperative clinical and oncological outcomes from both a patient’s and doctor’s point of view. This study aims to evaluate the incidence of TOO in patients receiving robotic colorectal cancer surgery in five robotic colorectal units and understand the risk factors associated with failure to achieve a TOO in these patients. Methods: We present a retrospective, multicentric study with data from a prospectively collected database. All consecutive patients receiving robotic colorectal cancer resections from five centres between 2013 and 2022 were included. Patient characteristics and short-term clinical and oncological data were collected. A TOO was achieved when all components were realized—no conversion to open, no complication with a Clavien–Dindo (CD) ≥ 3, length of hospital stay ≤ 14, no 30-day readmission, no 30-day mortality, and R0 resection. The main outcome measure was a composite measure of “ideal” practice called textbook oncological outcomes. Results: A total of 501 patients submitted to robotic colorectal cancer resection were included. Of the 501 patients included, 388 (77.4%) achieved a TOO. Four patients were converted to open (0.8%); 55 (11%) had LOS > 14 days; 46 (9.2%) had a CD ≥ 3 complication; 30-day readmission rate was 6% (30); 30-day mortality was 0.2% (1); and 480 (95.8%) had an R0 resection. Abdominoperineal resection was a risk factor for not achieving a TOO. Conclusions: Robotic colorectal cancer surgery in robotic centres achieves a high TOO rate. Abdominoperineal resection is a risk factor for failure to achieve a TOO. This measure may be used in future audits and to inform patients clearly on success of treatment.